Association of polymorphisms in CTLA-4, IL-1ra and IL-1β genes with multiple sclerosis in Serbian population

被引：30
作者：
Dincic, Evica
Zivkovic, Maja
Stankovic, Aleksandra
Obradovic, Dragana
Alavantic, Dragan
Kostic, Vladimir
Raicevic, Ranko
机构：
[1] Vinca Inst Nucl Sci, Lab Radiobiol & Mol Genet, Belgrade 11001, Serbia
[2] Mil Med Acad, Dept Neurol, Belgrade 11001, Serbia
[3] Clin Ctr Serbia, Inst Neurol, Belgrade, Serbia
来源：
JOURNAL OF NEUROIMMUNOLOGY | 2006年 / 177卷 / 1-2期
关键词：
IL-1; beta; IL-1ra; CTLA-4; gene; polymorphisms; multiple sclerosis;
D O I：
10.1016/j.jneuroim.2006.05.005
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
We have investigated separate as well as combined influence of IL-1 beta TaqI, IL-1ra VNTR and CTLA-4 +49 A/G polymorphisms on susceptibility, clinical course and progression of MS in 162 Serbian patients. We found significant independent relative risk for MS susceptibility in noncarriers of IL-Ira allele 2 (OR=2.2, CI= 1.3-3.7, p=0.003) and CTLA-4 +49 AA genotype (OR=2.0, CI=1.2-3.5, p=0.01) as well as their combined effect (OR=4.4, CI=2.0-9.7, p=0.0003). Our result supports the significant and combined effect of IL-1ra VNTR and CTLA-4 polymorphisms on MS justifying the need for further haplotype analysis in different populations. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码：146 / 150
页数：5
相关论文
共 33 条
  • [1] INTERLEUKIN-1 RECEPTOR ANTAGONIST - A NEW MEMBER OF THE INTERLEUKIN-1 FAMILY
    AREND, WP
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (05) : 1445 - 1451
  • [2] Complex association analysis of Graves disease using a set of polymorphic markers
    Chistyakov, DA
    Savost'anov, KV
    Turakulov, RI
    Petunina, NA
    Trukhina, LV
    Kudinova, AV
    Balabolkin, MI
    Nosikov, VV
    [J]. MOLECULAR GENETICS AND METABOLISM, 2000, 70 (03) : 214 - 218
  • [3] DANIS VA, 1995, CLIN EXP IMMUNOL, V99, P303
  • [4] Production of IL-1β and IL-1Ra as risk factors for susceptibility and progression of relapse-onset multiple sclerosis
    de Jong, BA
    Huizinga, TWJ
    Bollen, ELEM
    Uitdehaag, BMJ
    Bosma, GPT
    van Buchem, MA
    Remarque, EJ
    Burgmans, ACS
    Kalkers, NF
    Polman, CH
    Westendorp, RGJ
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2002, 126 (1-2) : 172 - 179
  • [5] Combined effect of HLA-DRB1* 1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis
    delaConcha, EG
    Arroyo, R
    Crusius, JBA
    Campillo, JA
    Martin, C
    deSeijas, E
    Pena, AS
    Claveria, LE
    FernandezArquero, M
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1997, 80 (1-2) : 172 - 178
  • [6] CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus
    Donner, H
    Rau, H
    Walfish, PG
    Braun, J
    Siegmund, T
    Finke, R
    Herwig, J
    Usadel, KH
    Badenhoop, K
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (01) : 143 - 146
  • [7] No evidence to support CTLA-4 as a susceptibility gene in MS families: the Canadian Collaborative Study
    Dyment, DA
    Steckley, JL
    Willer, CJ
    Armstrong, H
    Sadovnick, AD
    Risch, N
    Ebers, GC
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2002, 123 (1-2) : 193 - 198
  • [8] CTLA-4 gene polymorphism may modulate disease in Japanese multiple sclerosis patients
    Fukazawa, T
    Yanagawa, T
    Kikuchi, S
    Yabe, I
    Sasaki, H
    Hamada, T
    Miyasaka, K
    Gomi, K
    Tashiro, K
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 171 (01) : 49 - 55
  • [9] Harbo HF, 1999, TISSUE ANTIGENS, V53, P106
  • [10] HARPER K, 1991, J IMMUNOL, V147, P1037
1234